Among the death receptors and their ligands, the TRAIL/TRAIL receptor system has gained most attention, since it preferentially triggers cell death in cancer cells compared to non-malignant cells, providing some tumor selectivity (Ashkenazi and Herbst, 2008; Humphreys and Halpern, 2008). The gene discussed is TNFSF10; the disease is cancer.